Healthcare Services company Thyrocare Technologies announced Q1FY26 results Q1FY26 Financial Highlights: Revenue from operations: Rs 193.03 crore compared to Rs 156.91 crore during Q1FY25, change 23%. EBITDA: Rs 57.46 crore compared to Rs 42.01 crore during Q1FY25, change 37% EBITDA Margin: 30% for Q1FY26. PAT: Rs 38.06 crore compared to Rs 23.47 crore during Q1FY25, change 62%. PAT Margin: 20% for Q1FY26. Business Highlights: Pathology Business - Franchise revenue grew by 20% YoY, while partnership revenue surged by 36% YoY. Total test volume reached 46.9 million in Q1FY26, reflecting a 15% YoY increase. Opened New Labs in Bhagalpur, Kashmir and Roorkee. Result PDF